Thompson, WD
Reynolds, RM
Beaumont, RN
Warrington, NM
Tyrrell, J
Wood, AR
Evans, DM
McDonald, TJ
Hattersley, AH
Freathy, RM
Lawlor, DA
Borges, MC
Funding for this research was provided by:
Medical Research Council (GW4 BIOMED DTP, MC_UU_00011/6, MC_UU_00011/6, MC_UU_00011/6)
British Heart Foundation (RE/18/5/34216)
Wellcome Trust (WT104150, 098395/Z/12/Z, WT104150)
Australian National Health (APP2008723, APP1137714)
NIHR senior clinical lectureship (ICA-SCL-2016-02-003)
NIHR Senior Investigator (NF-0616-10102)
Article History
Received: 13 August 2023
Accepted: 3 January 2024
First Online: 15 January 2024
Declarations
:
: For UK Biobank, all participants provided written informed consent, including for their collected data to be used by international scientists. UK Biobank has approval from the North West Multi-centre Research Ethics Committee (MREC), which covers the UK. UK Biobank’s research ethics committee and Human Tissue Authority research tissue bank approvals mean that researchers wishing to use the resource do not need separate ethics approval. For EFSOCH, all mothers and fathers gave informed consent and ethical approval was obtained from the North and East Devon Local Research Ethics Committee.
: This study does not use data that could be used as a means of identification.
: DAL has received support from Medtronic LTD and Roche Diagnostics for biomarker research that is not related to the study presented in this paper. The other authors report no conflicts.